Innovative Strategies for Blood-Brain Barrier (BBB) Permeability Modeling: Harnessing the Power of Machine Learning-based q-RASAR Approach

In the current research, we have unveiled an advanced technique termed the quantitative Read-Across Structure-Activity Relationship (q-RASAR) framework to harnesses the power of machine learning (ML) for significantly enhancing the precision of predictions related to blood-brain barrier (BBB) permeability. It is important to emphasize that the central objective of this study is not to introduce another model for predicting BBB permeability. Instead, our focus is on highlighting the improvement in predicting the BBB permeability of organic compounds by introducing the q-RASAR approach. This innovative methodology strives to enhance the precision of evaluating neuropharmacological implications and streamline the drug development process. In this investigation, we developed an ML-based q-RASAR PLS model using a dataset comprising 1012 compounds of diverse classes of heterocyclic and aromatic hydrocarbons, obtained from the freely accessible B3DB database (accessible at https://github.com/theochem/B3DB) to predict BBB permeability during the lead discovery phase for central nervous system (CNS) drugs. The model's predictive capability underwent validation using two external sets, encompassing a total of 1,130,315 compounds, including synthetic compounds and natural products (NPs) for data gap filling and other two external sets comprising 116 drug-like/drug compounds from FDA and ChEMBL databases to assess the model's reliability. This study aimed to bridge the data gap by employing a predictive model to estimate the impact of brain-plasma concentration ratios on BBB permeability for both synthetic compounds and natural products (NPs). To further enhance predictability, we have developed various other ML-based q-RASAR models. The insights from the developed model highlight the pivotal roles played by hydrophobicity, electronic effects, degree of ionization and steric factors as essential features facilitating the traversal of the blood-brain barrier. This research not only advances our understanding of the molecular determinants influencing the permeability of central nervous system drugs but also establishes a versatile computational platform for the rapid assessment of diverse compounds, facilitating informed decision-making in the realms of drug development and design.